-
Letrozole, sold
under the
brand name
Femara among others, is an
aromatase inhibitor medication that is used in the
treatment of
breast cancer for post-menopausal...
-
survival in
patients on
palbociclib in
combination with
letrozole,
compared to
patients on
letrozole and placebo. Progression-free
survival was ****essed by...
- [citation needed] A
study of 150
babies following treatment with
letrozole or
letrozole and follicle-stimulating
hormone presented at the
American Society...
-
children and adolescents.
Ovarian stimulation with the
aromatase inhibitor letrozole has been
proposed for
ovulation induction in
order to
treat unexplained...
-
endometrial carcinoma, hyperprolactinaemia.
Among all
aromatase inhibitors,
Letrozole is
commonly used for
improving female fertility. It
works by inhibiting...
-
anastrozole and
letrozole. They are used as first-line
therapy in
metastatic breast cancer and also in
adjuvant treatment. The NSAI,
letrozole is also used...
- risk of recurrence. Additionally, the FDA
approved the
ribociclib and
letrozole co-pack for the same indication. In
November 2024, the
European Commission...
-
penetration of
anastrozole in rodents,
whereas this was not the case with
letrozole and vorozole. As such,
anastrozole may have
peripheral selectivity in...
- anovulation, but it
appears less
effective than
letrozole or clomiphene. For
women not
responsive to
letrozole or
clomiphene and diet and
lifestyle modification...
- For
treatment of
precocious puberty, the
aromatase inhibitor such as
letrozole is
effective at
prevent bleeding episodes and
preventing short stature...
